Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20120214009011N3Phase 2Completed
Phase 2, randomised, double-blind trial in delirium comparing Melatonin arm with Dexmedetomidine arm (2 arms). Primary endpoint: Delirium. Started May 2024; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20120214009011N3.